In the May Antibody Update, you can expect to find news of an enzyme inhibitor that increases the efficacy of anti-PD-1 Immunotherapy, the generation of induced pluripotent blood stem cells, and the rapid employment of the latest Ebola vaccine in the Democratic Republic of the Congo. Learn more at ProSci.
Read More
December 2016: The Antibody Update
ProSci's last Antibody Update of 2016 includes the super effective Ebola vaccine developed by Merck, using the common diabetes drug metformin and the antihypertensive syrosingopine to combat cancer, and a link to a highlight review of the immune checkpoint TIGIT. Check it out!
Read MoreJanuary 2016: The Antibody Update
The January 2016 Antibody Update covers a study on the monoclonal antibody Natalizumab's unfortunate side effects, cross reactivity of anti-Ebola virus antibodies, and the controversial Hero's of CRISPR paper, excluding Jennifer Doudna's work.
